Esperion Therapeutics Inc
Esperion Therapeutics Inc (ESPR) is known on NASDAQ - United States, but Bullrun does not have financial statement history attached to this listing yet.
Key Metrics
- TickerESPR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Financial periodQ1 2026
- RevenueUSD 80.10M
- Net income-USD 25.20M
- Free cash flow-USD 27.91M
- Gross margin56.8%